Neoadjuvant Therapy as a Selection Strategy for Curative Resection in High-Risk Intrahepatic Cholangiocarcinoma.

Saved in:
Bibliographic Details
Title: Neoadjuvant Therapy as a Selection Strategy for Curative Resection in High-Risk Intrahepatic Cholangiocarcinoma.
Authors: Dong Y; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.; Department of Surgery, HPB Center, Vienna Health Network, Clinic Favoriten, Sigmund Freud Private University, Vienna, Austria., Lewis KA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pereyra D; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Li Z; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.; William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA., Podrascanin V; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.; University Hospital Wiener Neustadt, Wiener Neustadt, Austria., Gist GC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Santol J; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.; Department of Surgery, HPB Center, Vienna Health Network, Clinic Favoriten, Sigmund Freud Private University, Vienna, Austria., Ammann M; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.; University Hospital Wiener Neustadt, Wiener Neustadt, Austria., Kankeu Fonkoua LA; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Graham RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Conboy CB; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Tran NH; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Warner SG; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Newhook TE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cao HST; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Smoot RL; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Starlinger P; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. starlinger.patrick@mayo.edu.; Institute of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University Vienna, Vienna, Austria. starlinger.patrick@mayo.edu.
Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Aug; Vol. 33 (8), pp. 7023-7035. Date of Electronic Publication: 2026 May 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-026-19729-4